MACOM Technology Solutions Holdings, Inc.'s Senior Vice President and Chief Financial Officer, John Kober, executed a sale of company stock on February 17, 2026, according to a recent SEC filing. The filing shows Kober sold 7,039 shares of common stock at prices spanning $236.42 to $247.70, producing an aggregate transaction value of about $1.75 million.
The disclosed trades were made under a pre-established trading plan adopted on August 14, 2025, structured to comply with Rule 10b5-1 of the Securities Exchange Act of 1934. After the reported dispositions, Kober is listed as directly owning 48,508 shares of MACOM.
The sales coincided with MACOM shares trading near their 52-week high of $250, with the stock having returned approximately 96% over the prior 12 months. Separately, analysis available via InvestingPro indicates the stock presently appears overvalued relative to its Fair Value, with more detailed assessment accessible through that platform's Pro Research Report.
Company results and analyst reaction
MACOM released first-quarter fiscal 2026 results that exceeded internal guidance and sell-side estimates. Revenue for the quarter reached $271.6 million, topping both the company guidance midpoint and analyst consensus of $269.0 million. Adjusted earnings per share were reported at $1.02, above the forecasted $0.9973.
The quarterly performance represented a 4.0% sequential increase and a 24.5% year-over-year rise in sales. Management and analysts have pointed to a record backlog and a book-to-bill ratio of 1.3 as supporting evidence of sustained demand across MACOM's end markets.
Following the earnings release, Benchmark raised its price target for MACOM to $260 while maintaining a Buy rating. Stifel also lifted its target to $255 and kept a Buy recommendation. The firms cited the company's strong quarter and guidance as the primary reasons for their continued positive stance.
Context and implications
The insider sale, completed under a Rule 10b5-1 plan established in August 2025, represents a formal mechanism for company insiders to transact in equity while addressing timing and compliance considerations. The company-level results and sell-side responses underscore robust performance during the quarter, balanced by third-party analysis noting potential overvaluation versus Fair Value.
Readers should note that the filing, the company financials, analyst actions, and the InvestingPro assessment are the facts disclosed in public documents and research summaries; additional interpretation or forecasting beyond those items is not provided here.